Plasma cellular fibronectin as a measure of endothelial involvement in preeclampsia and intrauterine growth retardation
- 1 March 1994
- journal article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 170 (3), 838-841
- https://doi.org/10.1016/s0002-9378(94)70295-0
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Pathophysiology of PreeclampsiaClinics in Perinatology, 1991
- High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension aloneAmerican Journal of Obstetrics and Gynecology, 1991
- Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1990
- Preeclampsia: An endothelial cell disorderAmerican Journal of Obstetrics and Gynecology, 1989
- Differential expression of the ed sequence-containing form of cellular fibronectin in embryonic and adult human tissuesJournal of Cell Science, 1987
- Inadequate maternal vascular response to placentation in pregnancies complicated by pre‐eclampsia and by small‐for‐gestational age infantsBJOG: An International Journal of Obstetrics and Gynaecology, 1986
- Changes in serum uric acid concentrations during normal pregnancyBJOG: An International Journal of Obstetrics and Gynaecology, 1984
- The factor VIII ratio in normal and pathological pregnanciesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1983
- FACTOR VIII RELATED ANTIGEN/COAGULANT ACTIVITY RATIO AS A PREDICTOR OF FETAL GROWTH RETARDATION: A COMPARISON WITH HORMONE AND URIC ACID MEASUREMENTSBJOG: An International Journal of Obstetrics and Gynaecology, 1980
- An Analysis of TransformationsJournal of the Royal Statistical Society: Series B (Methodological), 1964